ARDS
PINK Aridis Pharmaceuticals, Inc.$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0001
- YTD change
- -93.33%
- vs 20-day SMA
- +0.00%
- vs 200-day SMA
- -79.34%
Price ranges
Price & Performance
-0.00 (-50.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.8% away from all-time highs of $0.0500
- ARDS is down 93% since the beginning of the year
- ARDS is down 50% over the past 12 months
- ARDS is up 0% over the past 1 month
- 0% of all ARDS investors are betting against ARDS
ARDS reads n/a: price sits above one of the two key moving averages, the 12-month move is -50.0%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +0.00%
- vs 8-day SMA
- +0.00%
No alerts for ARDS in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.